10Rx Semaglutide Cost: Is the $299 Quarterly Plan a Good Deal?

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

10Rx charges $299 for a three-month supply of compounded semaglutide injection—$99.67 per month when you pay the full quarter upfront (secondary-corroborated figure, captured September 4, 2026). That prepaid per-month equivalent is lower than most month-to-month options and beats PlexusDx's $189 month-to-month rate. Over 12 months, 10Rx's quarterly model costs $1,196 total versus PlexusDx's $2,268 month-to-month or $2,028 on a three-month commitment ($169/month). The tradeoff: 10Rx requires $299 every three months with no documented month-to-month flexibility, while PlexusDx offers month-to-month billing at $189 and a comparable three-month commitment tier at $169/month. If you're comfortable prepaying quarterly and confident in sustained use, 10Rx's structure delivers a clear dollar advantage; if you want monthly flexibility or the option to pause without forfeiting prepaid funds, a month-to-month plan may suit better.

At a glance: 10Rx vs. PlexusDx semaglutide injection

Breaking down 10Rx's quarterly semaglutide plan structure

10Rx operates on a prepaid quarterly model: you pay $299 upfront for a three-month package of compounded semaglutide injection with B12 (secondary-corroborated figure, captured September 4, 2026). The quarterly price is flat across available dose strengths, so whether you're at 0.5 mg or 2.4 mg, the package cost remains $299. The same rate applies on renewal—there is no introductory discount or refill surcharge documented.

Dividing the $299 total by three months yields a per-month arithmetic equivalent of $99.67 (our calculation). This is not a month-to-month billing option; you prepay the full quarter. The package includes medication, a clinician evaluation, next-day shipping, and ongoing support, with no separate membership or service fee (all per 10Rx's pricing page, captured September 4, 2026).

Evidence note: 10Rx's primary website (https://www.take10rx.com/pricing, captured September 4, 2026) confirms the quarterly structure, flat-strength pricing, and inclusions but suppresses the numeric package total. The $299 semaglutide figure is secondary-corroborated and should be verified at checkout.

Like-for-like comparison: quarterly prepaid vs. 3-month commitment

To compare fairly, we place 10Rx's prepaid quarterly plan alongside PlexusDx's three-month commitment tier (the closest structural analog) and also show PlexusDx's month-to-month option for readers who prioritize billing flexibility.

Over 12 months, 10Rx's prepaid quarterly structure costs $1,196 total—$832 less than PlexusDx's three-month commitment tier ($2,028) and $1,072 less than PlexusDx's month-to-month option ($2,268). Put another way, 10Rx's prepaid per-month equivalent ($99.67) is 41% lower than PlexusDx's $169 three-month rate and 47% lower than the $189 month-to-month rate.

The cost advantage is real, but it comes with a structural commitment: you prepay $299 every three months with no documented pause or month-to-month fallback. If treatment is interrupted or side effects require a break, the prepaid funds remain spent. PlexusDx's month-to-month option lets you pause after any single month without forfeiting future payments; the three-month commitment tier offers a middle ground—lower per-month cost than month-to-month, monthly billing, and a defined commitment window.

What else to consider: prepaid structure, evidence quality, and service baseline

Prepaid quarterly model: cash-flow tradeoff

10Rx's $299 quarterly prepayment lowers the per-month arithmetic but requires three months of capital upfront. For the first quarter, that's $299 on day one versus $189 on day one for PlexusDx month-to-month (and then $189 again in months two and three, totaling $567 over three months vs. $299 prepaid). If cash flow or the ability to stop without losing prepaid funds matters, month-to-month billing may be worth the higher per-month rate. If you're confident in sustained use and prefer locking in a lower average cost, the prepaid structure works in your favor.

Evidence status: secondary corroboration

The $299 semaglutide and $450 tirzepatide quarterly totals for 10Rx are secondary-corroborated figures (captured September 4, 2026). 10Rx's primary pricing page confirms the quarterly model, flat pricing across dose strengths, and all-inclusive package (medication, clinician evaluation, next-day shipping, support) but does not display the numeric package totals publicly. We advise readers to verify the exact quarterly cost at checkout and confirm there are no add-on fees or undisclosed charges before submitting payment.

Review baseline: limited public feedback for 10Rx

10Rx does not have a Trustpilot profile as of September 4, 2026. A Reddit search located one thread (r/tirzepatidecompound) but yielded no attributable negative themes or detailed service reports in our capture. This is neutral—absence of reviews is not a negative, but it means less public service-quality signal for prospective patients.

PlexusDx, for context, holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). Readers weighing a newer prepaid-only provider against an established service with documented patient feedback may find that review baseline helpful.

Choose 10Rx if…

• You are confident in sustained GLP-1 use over multiple quarters and want the lowest per-month arithmetic ($99.67 prepaid equivalent).
• Prepaying $299 every three months fits your cash flow and you do not anticipate needing to pause mid-quarter.
• You prefer a simple quarterly package with flat pricing across dose strengths and no separate membership fees.
• You are comfortable with secondary-corroborated pricing evidence and plan to verify the exact quarterly total at checkout.
• The absence of a public Trustpilot profile or extensive review history does not concern you.

Choose PlexusDx if…

• You want month-to-month billing flexibility ($189/month) with the ability to pause after any single month without forfeiting prepaid funds.
• You prefer a three-month commitment tier ($169/month, billed monthly) that balances lower cost with defined commitment rather than full quarterly prepayment.
• Publicly documented service quality matters—PlexusDx's 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher, captured September 9, 2026) provides a patient-feedback baseline.
• You value transparent, primary-source pricing published on product pages with no need for secondary corroboration.
• You want the option to escalate to a 6-month commitment tier ($149/month) for further per-month savings without prepaying an entire quarter upfront.

Tirzepatide comparison: 10Rx vs. PlexusDx

For readers considering tirzepatide instead of semaglutide, the same structural dynamics apply. 10Rx charges $450 for a three-month tirzepatide package ($150/month prepaid equivalent, secondary-corroborated, captured September 4, 2026). PlexusDx tirzepatide injection plans are $289 month-to-month, $269/month on a three-month commitment, and $249/month on a six-month commitment.

Over 12 months, 10Rx's tirzepatide prepaid plan costs $1,800 total versus PlexusDx's $3,228 on a three-month commitment or $3,468 month-to-month—a savings of $1,428 to $1,668 (our calculation). The same cash-flow and flexibility tradeoffs apply: 10Rx requires $450 upfront every quarter; PlexusDx bills monthly and allows pause after any month without forfeiting future payments.

Methodology and freshness

All 10Rx pricing and plan details were captured on September 4, 2026, from secondary-corroborated sources; 10Rx's primary pricing page (https://www.take10rx.com/pricing, verified September 4, 2026) confirms the quarterly structure, flat-strength pricing, and inclusions but suppresses numeric package totals. PlexusDx pricing reflects canonical rates from product pages. Review data (Trustpilot rating, Reddit search) captured September 4, 2026. All 12-month cost totals and prepaid per-month equivalents are our calculations, derived by multiplying documented quarterly or monthly rates by the appropriate cycle count. No payment was submitted to 10Rx in the verification pass; readers should confirm all figures at checkout. This comparison was prepared on September 7, 2026.

Frequently Asked Questions

Does 10Rx offer month-to-month semaglutide billing?

No. 10Rx operates on a prepaid quarterly model—$299 every three months for semaglutide (secondary-corroborated, captured September 4, 2026). There is no documented month-to-month option. If you want monthly billing flexibility, PlexusDx offers $189/month with no commitment or $169/month on a three-month commitment tier.

Is 10Rx's prepaid per-month arithmetic truly cheaper than PlexusDx?

Yes, the prepaid per-month arithmetic ($99.67) is lower than PlexusDx's $189 month-to-month and $169 three-month commitment rates. However, 10Rx requires $299 upfront every quarter, so the first three months cost $299 total versus $567 for PlexusDx month-to-month ($189 × 3) or $507 for the three-month tier ($169 × 3). Over 12 months, 10Rx costs $1,196 versus PlexusDx's $2,028 or $2,268, a substantial savings if you complete all four quarters.

What happens if I need to pause 10Rx mid-quarter?

10Rx's cancellation and refund terms are not documented in available sources (as of September 4, 2026). Because the model is prepaid quarterly, interrupting treatment mid-cycle may mean forfeiting part of the prepaid $299. Contact 10Rx directly to confirm their pause or refund policy before committing. PlexusDx's month-to-month plan lets you pause after any month without losing prepaid funds.

Does 10Rx's flat pricing across dose strengths apply to all semaglutide doses?

Yes. 10Rx's quarterly semaglutide package is priced at $299 regardless of dose strength (secondary-corroborated, captured September 4, 2026). Whether you are at 0.5 mg or 2.4 mg, the quarterly cost remains $299. PlexusDx also uses flat pricing across all semaglutide injection doses—$189 month-to-month, $169 on a three-month commitment, $149 on a six-month commitment.

How does 10Rx's tirzepatide pricing compare to PlexusDx?

10Rx charges $450 for a three-month tirzepatide package ($150/month prepaid equivalent, secondary-corroborated, captured September 4, 2026). PlexusDx tirzepatide injection is $289 month-to-month, $269/month on a three-month commitment, or $249/month on a six-month commitment. Over 12 months, 10Rx costs $1,800 total versus PlexusDx's $3,228 (three-month) or $3,468 (month-to-month)—a savings of $1,428 to $1,668 with 10Rx's prepaid model.

Sources

• 10Rx primary pricing page (https://www.take10rx.com/pricing), verified September 4, 2026
• 10Rx secondary-corroborated pricing evidence (semaglutide $299/quarter, tirzepatide $450/quarter), captured September 4, 2026
• PlexusDx semaglutide injection product page (https://plexusdx.com/products/semaglutide-injection), canonical pricing
• PlexusDx tirzepatide injection product page (https://plexusdx.com/products/tirzepatide-injection), canonical pricing
• Trustpilot search for 10Rx and PlexusDx review data, captured September 4, 2026
• Reddit search (r/tirzepatidecompound), captured September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.